{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T12:04:06Z","timestamp":1789128246695,"version":"build-2803163510"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","award":["4020017"],"award-info":[{"award-number":["4020017"]}],"id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ijbiomac.2025.145236","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T06:26:56Z","timestamp":1750055216000},"page":"145236","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"P3","title":["Targeted delivery of doxorubicin toward 4\u00a0T1 cells via in situ binding between maleimide functionalized AS1411\u00a0\u2212\u00a0NH2 aptamer and endogenous albumin"],"prefix":"10.1016","volume":"318","author":[{"given":"Yasamin","family":"Hamooni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Samie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Alibolandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Ramezani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalil","family":"Abnous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Mohammad","family":"Taghdisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2025.145236_bb0005","series-title":"Nanotherapeutic systems for drug delivery to brain tumors","first-page":"217","article-title":"Photophysics and nanophysics in therapeutics","author":"Moharir","year":"2022"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.145236_bb0010","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1002\/anie.202010934","article-title":"The trojan horse goes wild: the effect of drug loading on the behavior of nanoparticles","volume":"60","author":"Stenzel","year":"2021","journal-title":"Angew. Chem. Int. Ed."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.145236_bb0015","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.addr.2012.11.007","article-title":"Curb challenges of the \u201cTrojan horse\u201d approach: smart strategies in achieving effective yet safe cell-penetrating peptide-based drug delivery","volume":"65","author":"Huang","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.145236_bb0020","doi-asserted-by":"crossref","first-page":"2210262","DOI":"10.1002\/adma.202210262","article-title":"Trojan horse Nanocapsule enabled in situ modulation of the phenotypic conversion of Th17 cells to Treg cells for the treatment of multiple sclerosis in mice","volume":"35","author":"Shi","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ijbiomac.2025.145236_bb0025","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.addr.2018.07.011","article-title":"Harnessing albumin as a carrier for cancer therapies","volume":"130","author":"Hoogenboezem","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.145236_bb0030","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jconrel.2008.05.010","article-title":"Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles","volume":"132","author":"Kratz","year":"2008","journal-title":"J. Control. Release"},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.145236_bb0035","doi-asserted-by":"crossref","first-page":"5670","DOI":"10.1021\/acsami.7b00654","article-title":"Retraction of \u201cBSA protein-mediated synthesis of hollow mesoporous silica nanotubes, and their carbohydrate conjugates for targeting Cancer cells and detecting mycobacteria\u201d","volume":"9","author":"Hao","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.145236_bb0040","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0169-409X(96)00400-0","article-title":"The crucial role of spacer groups in macromolecular prodrug design","volume":"21","author":"Soyez","year":"1996","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"25","key":"10.1016\/j.ijbiomac.2025.145236_bb0045","first-page":"5523","article-title":"Probing the cysteine-34 position of endogenous serum albumin with thiol-binding doxorubicin derivatives","volume":"45","author":"Kratz","year":"2002","journal-title":"Improved efficacy of an acid-sensitive doxorubicin derivative with specific albumin-binding properties compared to that of the parent compound, Journal of medicinal chemistry"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.145236_bb0050","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jhep.2014.04.012","article-title":"Human serum albumin, systemic inflammation, and cirrhosis","volume":"61","author":"Arroyo","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ijbiomac.2025.145236_bb0055","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jconrel.2022.11.034","article-title":"Albumin-hitchhiking: fostering the pharmacokinetics and anticancer therapeutics","volume":"353","author":"Famta","year":"2023","journal-title":"J. Control. Release"},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.145236_bb0060","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1021\/acs.bioconjchem.8b00223","article-title":"Multifunctional tumor-targeting cathepsin B-sensitive gemcitabine prodrug covalently targets albumin in situ and improves cancer therapy","volume":"29","author":"Zhang","year":"2018","journal-title":"Bioconjug. Chem."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.145236_bb0065","doi-asserted-by":"crossref","first-page":"11369","DOI":"10.1021\/acsnano.1c00799","article-title":"A Trojan-horse strategy by in situ piggybacking onto endogenous albumin for tumor-specific neutralization of oncogenic MicroRNA","volume":"15","author":"Kwak","year":"2021","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.145236_bb0070","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jconrel.2011.07.031","article-title":"Albumin-based nanoparticles as potential controlled release drug delivery systems","volume":"157","author":"Elzoghby","year":"2012","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.145236_bb0075","article-title":"Use of intravenous albumin in the critically ill patient","volume":"86","author":"Guthrie","year":"1991","journal-title":"Am. J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.145236_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40591-016-0048-8","article-title":"Albumin-based drug delivery: harnessing nature to cure disease","volume":"4","author":"Larsen","year":"2016","journal-title":"Molecular and cellular therapies"},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.145236_bb0085","doi-asserted-by":"crossref","first-page":"5526","DOI":"10.1016\/j.bbagen.2013.04.023","article-title":"Albumin as a versatile platform for drug half-life extension","volume":"1830","author":"Sleep","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.145236_bb0090","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0031-6997(25)06849-8","article-title":"Molecular aspects of ligand binding to serum albumin","volume":"33","author":"Kragh-Hansen","year":"1981","journal-title":"Pharmacol. Rev."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.145236_bb0095","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/1869","article-title":"Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites","volume":"5","author":"Curry","year":"1998","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.ijbiomac.2025.145236_bb0100","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1749-6632.1987.tb33032.x","article-title":"Influence of endogenous albumin binding on blood-material interactions","volume":"516","author":"Eberhart","year":"1987","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.145236_bb0105","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1039\/D0TB01960G","article-title":"Targeted delivery and controlled release of doxorubicin to cancer cells by smart ATP-responsive Y-shaped DNA structure-capped mesoporous silica nanoparticles","volume":"9","author":"Bagheri","year":"2021","journal-title":"J. Mater. Chem. B"},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.145236_bb0110","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1080\/17425247.2022.2083602","article-title":"Synthesis of a targeted, dual pH and redox-responsive nanoscale coordination polymer theranostic against metastatic breast cancer in vitro and in vivo","volume":"19","author":"Falsafi","year":"2022","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ijbiomac.2025.145236_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2022.103285","article-title":"Dual-targeted delivery of doxorubicin by mesoporous silica nanoparticle coated with AS1411 aptamer and RGDK-R peptide to breast cancer in vitro and in vivo","volume":"71","author":"Hazeri","year":"2022","journal-title":"Journal of Drug Delivery Science and Technology"},{"key":"10.1016\/j.ijbiomac.2025.145236_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2024.106087","article-title":"Towards the preparation of smart drug delivery platforms for colorectal cancer therapy: biocompatible and targeted mesoporous silica nanoparticles with the deferiprone-copper complex gatekeeper","volume":"100","author":"Iranpour","year":"2024","journal-title":"Journal of Drug Delivery Science and Technology"},{"issue":"39","key":"10.1016\/j.ijbiomac.2025.145236_bb0125","doi-asserted-by":"crossref","first-page":"51837","DOI":"10.1021\/acsami.4c07040","article-title":"Stimuli-responsive covalent organic frameworks for Cancer therapy","volume":"16","author":"Nejabat","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.145236_bb0130","doi-asserted-by":"crossref","first-page":"11415","DOI":"10.1021\/acsami.4c14030","article-title":"Impact of Postsynthetic modification on the covalent organic framework (COF) structures","volume":"17","author":"Khojastehnezhad","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"6383","key":"10.1016\/j.ijbiomac.2025.145236_bb0135","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/358209a0","article-title":"Atomic structure and chemistry of human serum albumin","volume":"358","author":"He","year":"1992","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.145236_bb0140","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/protein\/12.6.439","article-title":"Crystal structure of human serum albumin at 2.5 \u00c5 resolution","volume":"12","author":"Sugio","year":"1999","journal-title":"Protein Eng."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.145236_bb0145","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.3390\/ijms21082793","article-title":"Aptamers, the nucleic acid antibodies, in cancer therapy","volume":"21","author":"Fu","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.145236_bb0150","first-page":"107","article-title":"AS-1411, a guanosine-rich oligonucleotide aptamer targeting nucleolin for the potential treatment of cancer, including acute myeloid leukemia","volume":"12","author":"Mongelard","year":"2010","journal-title":"Curr. Opin. Mol. Ther."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.145236_bb0155","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.yexmp.2009.01.004","article-title":"Discovery and development of the G-rich oligonucleotide AS1411 AS a novel treatment for cancer","volume":"86","author":"Bates","year":"2009","journal-title":"Exp. Mol. Pathol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.145236_bb0160","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.tcb.2006.11.010","article-title":"Nucleolin: a multiFACeTed protein","volume":"17","author":"Mongelard","year":"2007","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.ijbiomac.2025.145236_bb0165","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/bs.apcsb.2017.08.001","article-title":"Multifaceted nucleolin protein and its molecular partners in oncogenesis","volume":"111","author":"Ugrinova","year":"2018","journal-title":"Adv. Protein Chem. Struct. Biol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.145236_bb0170","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.bbagen.2016.12.015","article-title":"G-quadruplex oligonucleotide AS1411 as a cancer-targeting agent: uses and mechanisms","volume":"1861","author":"Bates","year":"2017","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijbiomac.2025.145236_bb0175","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.ijbiomac.2019.11.118","article-title":"Therapeutic applications of AS1411 aptamer, an update review","volume":"155","author":"Yazdian-Robati","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"issue":"26","key":"10.1016\/j.ijbiomac.2025.145236_bb0180","doi-asserted-by":"crossref","first-page":"27799","DOI":"10.1074\/jbc.M402898200","article-title":"Membrane topology of the DrrB protein of the doxorubicin transporter of Streptomyces peucetius","volume":"279","author":"Gandlur","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.145236_bb0185","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1124\/pr.56.2.6","article-title":"Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity","volume":"56","author":"Minotti","year":"2004","journal-title":"Pharmacol. Rev."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.145236_bb0190","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4103\/2231-4040.72251","article-title":"Various types and management of breast cancer: an overview","volume":"1","author":"Sharma","year":"2010","journal-title":"J. Adv. Pharm. Technol. Res."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.145236_bb0195","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.2042-7158.2012.01567.x","article-title":"Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems","volume":"65","author":"Tacar","year":"2013","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.145236_bb0200","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1023\/A:1007094214460","article-title":"Adriamycin-induced heart failure: mechanisms and modulation","volume":"207","author":"Singal","year":"2000","journal-title":"Mol. Cell. Biochem."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.145236_bb0205","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1021\/acs.molpharmaceut.1c00046","article-title":"The uniqueness of albumin as a carrier in nanodrug delivery","volume":"18","author":"Spada","year":"2021","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.145236_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-022-01240-z","article-title":"Progress in cancer drug delivery based on AS1411 oriented nanomaterials","volume":"20","author":"Tong","year":"2022","journal-title":"J. Nanobiotechnol."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2025.145236_bb0215","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ijpharm.2017.01.044","article-title":"Smart AS1411-aptamer conjugated pegylated PAMAM dendrimer for the superior delivery of camptothecin to colon adenocarcinoma in vitro and in vivo","volume":"519","author":"Alibolandi","year":"2017","journal-title":"Int. J. Pharm."},{"issue":"42","key":"10.1016\/j.ijbiomac.2025.145236_bb0220","doi-asserted-by":"crossref","first-page":"6432","DOI":"10.1039\/C9CE00929A","article-title":"Exploration of relative \u03c0-electron localization in naphthalene aromatic rings by C\u2013H\u22ef \u03c0 interactions: experimental evidence, computational criteria, and database analysis","volume":"21","author":"Samie","year":"2019","journal-title":"Crystengcomm"},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.145236_bb0225","doi-asserted-by":"crossref","first-page":"5090","DOI":"10.1021\/acs.molpharmaceut.3c00398","article-title":"Accelerated wound healing with a diminutive scar through Cocrystal engineered curcumin","volume":"20","author":"Samie","year":"2023","journal-title":"Mol. Pharm."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.145236_bb0230","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1039\/D2CE01171A","article-title":"Polymorphism in carboxamide compounds with high-Z\u2032 crystal structures","volume":"25","author":"Tavakoli-Quchani","year":"2023","journal-title":"CrystEngComm"},{"key":"10.1016\/j.ijbiomac.2025.145236_bb0235","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2014.21","article-title":"Cell-type-specific, aptamer-functionalized agents for targeted disease therapy","volume":"3","author":"Zhou","year":"2014","journal-title":"Mol. Ther.\u2013Nucleic Acids"},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.145236_bb0240","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.3390\/ijms18081683","article-title":"Chemical modifications of nucleic acid aptamers for therapeutic purposes","volume":"18","author":"Ni","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.145236_bb0245","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1021\/la103800h","article-title":"Effect of poly (ethylene glycol)(PEG) spacers on the conformational properties of small peptides: a molecular dynamics study","volume":"27","author":"Xue","year":"2011","journal-title":"Langmuir"},{"issue":"23","key":"10.1016\/j.ijbiomac.2025.145236_bb0250","doi-asserted-by":"crossref","first-page":"1900084","DOI":"10.1002\/adfm.201900084","article-title":"Tumor-specific aptamer-conjugated polymeric photosensitizer for effective Endo-laparoscopic photodynamic therapy","volume":"29","author":"Kim","year":"2019","journal-title":"Adv. Funct. Mater."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.145236_bb0255","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.7150\/thno.14858","article-title":"The smart drug delivery system and its clinical potential","volume":"6","author":"Liu","year":"2016","journal-title":"Theranostics"},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.145236_bb0260","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/1522-2683()22:6<1021::AID-ELPS1021>3.0.CO;2-B","article-title":"Detection of Saccharomyces cerevisiae carboxylesterase activity after native and sodium dodecyl sulfate electrophoresis by using fluorescein diacetate as substrate","volume":"22","author":"Lomolino","year":"2001","journal-title":"Electrophoresis"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.145236_bb0265","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1021\/mp800051m","article-title":"Factors affecting the clearance and biodistribution of polymeric nanoparticles","volume":"5","author":"Alexis","year":"2008","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.145236_bb0270","series-title":"Immunobiology of proteins and peptides IV: T-cell recognition and antigen presentation","first-page":"189","article-title":"Endosome acidification and the pathways of receptor-mediated endocytosis","author":"Maxfield","year":"1987"},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.145236_bb0275","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.cclet.2020.03.001","article-title":"pH-sensitive nanoscale materials as robust drug delivery systems for cancer therapy","volume":"31","author":"Shi","year":"2020","journal-title":"Chin. Chem. Lett."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.145236_bb0280","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3923\/ajdd.2011.24.48","article-title":"pH sensitive drug delivery systems: a review","volume":"1","author":"Balamuralidhara","year":"2011","journal-title":"American Journal of drug discovery and development"},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.145236_bb0285","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.4155\/tde.13.120","article-title":"pH-sensitive drug-delivery systems for tumor targeting","volume":"4","author":"He","year":"2013","journal-title":"Ther. Deliv."},{"issue":"25","key":"10.1016\/j.ijbiomac.2025.145236_bb0290","doi-asserted-by":"crossref","first-page":"28581","DOI":"10.1021\/acsami.2c05814","article-title":"Molecular and supramolecular approach to highly Photocytotoxic Phthalocyanines with dual cell uptake pathways and albumin-enhanced tumor targeting","volume":"14","author":"Liu","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.145236_bb0295","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1039\/C5CS00158G","article-title":"Simple bioconjugate chemistry serves great clinical advances: albumin as a versatile platform for diagnosis and precision therapy","volume":"45","author":"Liu","year":"2016","journal-title":"Chem. Soc. Rev."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.145236_bb0300","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.tox.2004.12.003","article-title":"Doxorubicin hepatotoxicity and hepatic free radical metabolism in rats: the effects of vitamin E and catechin","volume":"209","author":"Kalender","year":"2005","journal-title":"Toxicology"},{"key":"10.1016\/j.ijbiomac.2025.145236_bb0305","doi-asserted-by":"crossref","first-page":"1083780","DOI":"10.3389\/fimmu.2022.1083780","article-title":"Hepatocytes: a key role in liver inflammation","volume":"13","author":"Gong","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.145236_bb0310","doi-asserted-by":"crossref","first-page":"6945","DOI":"10.2147\/IJN.S467876","article-title":"Albumin nanoparticle-based drug delivery systems","volume":"19","author":"Qu","year":"2024","journal-title":"Int. J. Nanomedicine"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.145236_bb0315","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1021\/bc1002295","article-title":"Targeted albumin-based nanoparticles for delivery of amphipathic drugs","volume":"22","author":"Xu","year":"2011","journal-title":"Bioconjug. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.145236_bb0320","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.phrs.2010.10.012","article-title":"Improved drug targeting of cancer cells by utilizing actively targetable folic acid-conjugated albumin nanospheres","volume":"63","author":"Shen","year":"2011","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.145236_bb0325","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jconrel.2003.10.009","article-title":"Albumin nanoparticles improved the stability, nuclear accumulation and anticytomegaloviral activity of a phosphodiester oligonucleotide","volume":"94","author":"Arnedo","year":"2004","journal-title":"J. Control. Release"},{"issue":"23","key":"10.1016\/j.ijbiomac.2025.145236_bb0330","doi-asserted-by":"crossref","first-page":"6056","DOI":"10.3390\/ijms20236056","article-title":"Overcoming hurdles in nanoparticle clinical translation: the influence of experimental design and surface modification","volume":"20","author":"Shreffler","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.145236_bb0335","doi-asserted-by":"crossref","first-page":"8423","DOI":"10.1021\/acsnano.8b03900","article-title":"Quantifying the ligand-coated nanoparticle delivery to cancer cells in solid tumors","volume":"12","author":"Dai","year":"2018","journal-title":"ACS Nano"},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.145236_bb0340","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1021\/jm9905864","article-title":"A novel macromolecular prodrug concept exploiting endogenous serum albumin as a drug carrier for cancer chemotherapy","volume":"43","author":"Kratz","year":"2000","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.145236_bb0345","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1073\/pnas.2628032100","article-title":"Lymphocyte surface thiol levels","volume":"100","author":"Sahaf","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.145236_bb0350","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1080\/17425247.2018.1530656","article-title":"Targeted delivery of doxorubicin to cancer cells by a cruciform DNA nanostructure composed of AS1411 and FOXM1 aptamers","volume":"15","author":"Abnous","year":"2018","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ijbiomac.2025.145236_bb0355","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev.pharmtox.010909.105547","article-title":"Discovery and development of therapeutic aptamers","volume":"50","author":"Bouchard","year":"2010","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.145236_bb0360","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrd3141","article-title":"Aptamers as therapeutics","volume":"9","author":"Keefe","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2025.145236_bb0365","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jconrel.2018.12.014","article-title":"Applications of \u03c0-\u03c0 stacking interactions in the design of drug-delivery systems","volume":"294","author":"Zhuang","year":"2019","journal-title":"J. Control. Release"},{"issue":"49","key":"10.1016\/j.ijbiomac.2025.145236_bb0370","doi-asserted-by":"crossref","first-page":"45455","DOI":"10.1021\/acsami.9b16637","article-title":"Aptamer-based erythrocyte-derived mimic vesicles loaded with siRNA and doxorubicin for the targeted treatment of multidrug-resistant tumors","volume":"11","author":"Wang","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.145236_bb0375","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1021\/acsnano.0c06136","article-title":"DNA nanostructures: current challenges and opportunities for cellular delivery","volume":"15","author":"Lacroix","year":"2021","journal-title":"ACS Nano"},{"issue":"32","key":"10.1016\/j.ijbiomac.2025.145236_bb0380","doi-asserted-by":"crossref","first-page":"13396","DOI":"10.1021\/ja304263n","article-title":"DNA origami as a carrier for circumvention of drug resistance","volume":"134","author":"Jiang","year":"2012","journal-title":"J. Am. Chem. Soc."},{"issue":"41","key":"10.1016\/j.ijbiomac.2025.145236_bb0385","doi-asserted-by":"crossref","first-page":"12702","DOI":"10.1002\/ange.201706301","article-title":"DNA Trojan horses: self-assembled Floxuridine-containing DNA Polyhedra for Cancer therapy","volume":"129","author":"Mou","year":"2017","journal-title":"Angew. Chem."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.145236_bb0390","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2174\/1872211311666170328151455","article-title":"Environmentally responsive systems for drug delivery","volume":"11","author":"Bruschi","year":"2017","journal-title":"Recent Pat. Drug Deliv. Formul."},{"issue":"29","key":"10.1016\/j.ijbiomac.2025.145236_bb0395","doi-asserted-by":"crossref","first-page":"7946","DOI":"10.1039\/C5OB01205H","article-title":"A platform for efficient, thiol-stable conjugation to albumin\u2019s native single accessible cysteine","volume":"13","author":"Smith","year":"2015","journal-title":"Org. Biomol. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.145236_bb0400","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/chem.201803174","article-title":"Bioconjugation with maleimides: a useful tool for chemical biology","volume":"25","author":"Ravasco","year":"2019","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.ijbiomac.2025.145236_bb0405","series-title":"Targeted drug delivery to tumors: myths, reality and possibility","first-page":"198","author":"Bae","year":"2011"},{"key":"10.1016\/j.ijbiomac.2025.145236_bb0410","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jconrel.2019.01.014","article-title":"KRAS-enhanced macropinocytosis and reduced FcRn-mediated recycling sensitize pancreatic cancer to albumin-conjugated drugs","volume":"296","author":"Liu","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2025.145236_bb0415","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2020.08.015","article-title":"Controlled loading of albumin-drug conjugates ex vivo for enhanced drug delivery and antitumor efficacy","volume":"328","author":"Liu","year":"2020","journal-title":"J. Control. Release"},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.145236_bb0420","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.7150\/thno.16358","article-title":"Targeting negative surface charges of cancer cells by multifunctional nanoprobes","volume":"6","author":"Chen","year":"2016","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.145236_bb0425","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s41048-018-0080-0","article-title":"Detection of cancer cells based on glycolytic-regulated surface electrical charges","volume":"5","author":"Wenjun","year":"2019","journal-title":"Biophys. Rep."},{"issue":"13","key":"10.1016\/j.ijbiomac.2025.145236_bb0430","doi-asserted-by":"crossref","first-page":"4736","DOI":"10.1002\/cam4.3067","article-title":"The neonatal fc receptor in cancer FcRn in cancer","volume":"9","author":"Cadena Castaneda","year":"2020","journal-title":"Cancer Med."},{"key":"10.1016\/j.ijbiomac.2025.145236_bb0435","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.colsurfb.2018.02.024","article-title":"Albumin-covered lipid nanocapsules exhibit enhanced uptake performance by breast-tumor cells","volume":"165","author":"Galisteo-Gonz\u00e1lez","year":"2018","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.ijbiomac.2025.145236_bb0440","doi-asserted-by":"crossref","first-page":"108750","DOI":"10.1016\/j.biopha.2019.108750","article-title":"Strategies for the production of long-acting therapeutics and efficient drug delivery for cancer treatment","volume":"113","author":"AlQahtani","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"50","key":"10.1016\/j.ijbiomac.2025.145236_bb0445","doi-asserted-by":"crossref","first-page":"43482","DOI":"10.1021\/acsami.8b17399","article-title":"Long-circulating amphiphilic doxorubicin for tumor mitochondria-specific targeting","volume":"10","author":"Xi","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"21","key":"10.1016\/j.ijbiomac.2025.145236_bb0450","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S1359-6446(05)03575-0","article-title":"PEGylation, successful approach to drug delivery","volume":"10","author":"Veronese","year":"2005","journal-title":"Drug Discov. Today"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.145236_bb0455","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/sj.ki.5000141","article-title":"Renal albumin absorption in physiology and pathology","volume":"69","author":"Birn","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.ijbiomac.2025.145236_bb0460","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.freeradbiomed.2013.05.050","article-title":"The thiol pool in human plasma: the central contribution of albumin to redox processes","volume":"65","author":"Turell","year":"2013","journal-title":"Free Radic. Biol. Med."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.145236_bb0465","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.3390\/jpm12121964","article-title":"Enhanced permeability and retention effect as a ubiquitous and epoch-making phenomenon for the selective drug targeting of solid tumors","volume":"12","author":"Islam","year":"2022","journal-title":"Journal of Personalized Medicine"},{"key":"10.1016\/j.ijbiomac.2025.145236_bb0470","series-title":"Guiding factors and surface modification strategies for biomaterials in pharmaceutical product development","first-page":"57","article-title":"Biomaterials and Bionanotechnology","author":"Maheshwari","year":"2019"},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.145236_bb0475","doi-asserted-by":"crossref","first-page":"4860","DOI":"10.1021\/acs.molpharmaceut.4c00786","article-title":"A perspective on the permeability of Cocrystals\/organic salts of Oral drugs","volume":"21","author":"Samie","year":"2024","journal-title":"Mol. Pharm."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.145236_bb0480","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1021\/acs.cgd.5c00077","article-title":"Crystal engineering strategies for optimizing skin permeation","volume":"25","author":"Samie","year":"2025","journal-title":"Cryst. Growth Des."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.145236_bb0485","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1517\/17425247.2015.993313","article-title":"Albumin and its application in drug delivery","volume":"12","author":"Sleep","year":"2015","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ijbiomac.2025.145236_bb0490","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jconrel.2015.06.006","article-title":"The role of albumin receptors in regulation of albumin homeostasis: implications for drug delivery","volume":"211","author":"Bern","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2025.145236_bb0495","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jconrel.2021.01.033","article-title":"Hyaluronic acid and albumin based nanoparticles for drug delivery","volume":"331","author":"Lei","year":"2021","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.145236_bb0500","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jconrel.2010.08.011","article-title":"RVG peptide tethered bioreducible polyethylenimine for gene delivery to brain","volume":"155","author":"Son","year":"2011","journal-title":"J. Control. Release"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025057897?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025057897?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:44:13Z","timestamp":1752799453000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025057897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":100,"alternative-id":["S0141813025057897"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.145236","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted delivery of doxorubicin toward 4\u00a0T1 cells via in situ binding between maleimide functionalized AS1411\u00a0\u2212\u00a0NH2 aptamer and endogenous albumin","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.145236","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"145236"}}